MetLife posts Q4 adjusted earnings available to common shareholders of USD 97 million

Reuters
Feb 05
MetLife posts Q4 adjusted earnings available to common shareholders of USD 97 million

MetLife Inc. reported fourth quarter (Q4) 2025 premiums, fees and other revenues of USD 18.7 billion, representing a 29 percent increase compared to the prior-year quarter. Adjusted premiums, fees and other revenues, excluding pension risk transfers, totaled USD 12.8 billion, up 8 percent. Adjusted earnings available to common shareholders for Q4 2025 were USD 97 million. For the full year (FY) 2025, adjusted earnings available to common shareholders reached USD 367 million. Adjusted premiums, fees and other revenues for Q4 2025 were USD 787 million, while for FY 2025 these amounted to USD 2.90 billion. MetLife has provided additional supplemental slides for the fourth quarter, as well as further information about its diversified global investment portfolio, available on its Investor Relations website.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Metlife Inc. published the original content used to generate this news brief on February 04, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10